The mitogen-activated protein kinase (MAPK) pathway comprised of the RAS-RAF-MEK-ERK signalling cascade is deregulated due to somatic gene mutation in >50 % of CRC, with 40 % of these due to activating mutations in KRAS [37]. The gene discussed is KRAS; the disease is colorectal carcinoma.